Presentation at the EHiN-FN and European Telemedicine conference 2016
2B Kalfhaus Opportunities and Challenges of Telemedicine EHiN 2014
-
Upload
ikt-norge -
Category
Healthcare
-
view
114 -
download
0
description
Transcript of 2B Kalfhaus Opportunities and Challenges of Telemedicine EHiN 2014
Connect, Engage and Take Decisions
Opportunities and Challenges of Telemedicine Implementation
Lars Kalfhaus | Oslo, 03. November 2014
The Market …
Now is the time!(?)
The Telemedicine Promise & Challenges
The Market …
Telemedicine
eHealth
mHealth
mHealth = Telemedicine reloaded
Worldwide Market Size and Growth
research2guidance; March 2013
(US$ millions)
research2guidance; March 2013
Main Professional and non-Professional Target Groups
Market Potential by Therapeutic Area
research2guidance; March 2013
Commissioner Tonio Borg, 04 April 2014IDF, Diabetes Atlas 6th edition, 2013Research2guidance; March 2013Internal data
€0,4 bnmHealth Market
• mHealth market by
2017: €5,7 bn
• Preventable costsfrom better chronicdisease managementand efficiency gains:
> €140 bn (in 2013)
2013
Market Potential revisited
Now is the time!(?)
Josep Valor; IESELars Kalfhaus (for QS)
Fundamental Global Trends
Fundamental Global Trends - SOCIAL
SOCIAL
Fundamental Global TrendsFundamental Global Trends - SOCIAL
Fundamental Global Trends
250,000 members
Fundamental Global Trends - SOCIAL
Fundamental Global TrendsFundamental Global Trends - SOCIAL
Fundamental Global Trends
MOBILE
Fundamental Global Trends - MOBILE
Devices Regions
Fundamental Global Trends – BIG DATA
BIG DATA
Fundamental Global Trends – BIG DATA
Fundamental Global Trends – BIG DATA
Fundamental Global Trends – BIG DATA
US Department of LabourWipro Applying Thought
Fundamental Global Trends – QUANTIFIED SELF
QUANTIFIED SELF
Fundamental Global TrendsFundamental Global Trends – QUANTIFIED SELF
Fundamental Global TrendsFundamental Global Trends – QUANTIFIED SELF
With theinstalled base of medical devices
Today > 500.000data points
ThisWeek
> 3.500.000data points
… Norway
Nothing new for people with diabetes!
The Telemedicine Promise & Challenges
No Significant Improvements in Diabetes Management
Diabetes related drugs and medical
devices
320 OADs
10 GLPs
150 Insulins
> 200 Med. Dev.
… despite access to and availability of innovative pharmacological treatment options
Severe
Moderate
Mild
General Population
x2
x6
x24
Kaiser PermanentePlan de Chronicos Navarra
• Promote health living, prevention and good health
• Avoid disease progression and comorbidities
• Find adequate balance and tools for integrating self-care and professional care
Costs
Cost Burden as a Consequence of Suboptimal Diabetes Management
Value =Health outcome
Cost of delivering the outcome
• Prevention
• Early detection
• Quality of Life
• Prevention of complications
• Less hospitalization
• Slower disease progression
• Faster recovery
• Fewer recurrences ...
… the enabling technology platform
Michael Porter; Redesigning Helathcare
The Promise of Telemedicine
Better health is the goal, not more or less treatment
Access, equity, quality and cost effectiveness
Michael Porter; Redesigning HelathcareGlobal Observatory for eHealth Series – Volume 2; who.int
The Goal
Personalized Diabetes Management Cycle – Enabled by Technology
Ceriello et al; Diabetes as a case study of chronic disease management with a personalized approach: the role of a structured feedback loop; Diabetes Res Clin Pract. 2012 Oct
Key Considerations
… on the way to fully capture the Telemedicine promise
Business Telemedicine Legal
Organizational
Political
Business Considerations …
• Glocalization
• Interoperability
• Co-creation
• Integration
• Pricing and revenue models
New Business Models needed
PWC – EIU; mHealth
Organizational Considerations …
Organizational Considerations …
• Process and cultural change on how care is delivered
• Alignment of KPIs and incentive schemes for healthcare workers
• Development and acceptance of new study designs (beyond classical clinical evidence) to assess effectiveness
• Willingness to engage in co-creation and overcome classical barriers and role definitions between stakeholders
• Build confidence and trust between all stakeholders
• Coherent policy making that encourages competition centered around patient value over the entire care cycle
Political Considerations …
• Data protection, patient safety and privacy is a top priority
• Regulatory aspects: Medical Devices (classes) boundary between MD and non regulated products – interoperability between the two
… technology changes faster than legal and regulatory framework
Changes in contractual framework especially public sector procurement and tender legislation
Legal Considerations …
• The business potential of Telemedicine could be far greater than generally estimated
• It will require (and enable) fundamental restructuring of healthcare delivery
• Co-creating and collaboration between stakeholders will be key in a value-creation approach on what the technology should accomplish
To Sum Up …